Overview

Neuroprosthetics Market is forecasted to value over USD 14.1 billion by 2027 end and register a CAGR of 11.8% from the forecast period 2020-2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Neuroprosthetics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market .
According to the research study conducted by FutureWise research analysts, the Neuroprosthetics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Neuroprosthetics Market are    

• Medtronic
• Abbott
• Cochlear
• Boston Scientific
• Livanova
• Second Sight
• Livanova
• Med-El
• Retina Implant
• Sonova
• Neuropace
• NDI Medical
• Nevro

 (Note: The list of the major players will be updated with the latest market scenario and trends)

Neuroprosthetics Market  Segmentation:

By Type

• Output Neural Prosthetics
• Motor Prosthetics
• Cognitive Prosthetics
•  Input Neural Prosthetics
• Cochlear Implants
• Bionic Eye/Retinal Implants

By Application

• Motor Neuron Disorders
• Parkinson’s Disease
• Epilepsy
• Physiological Disorders
• Auditory Processing Disorders
• Ophthalmic Disorders
• Cardiovascular Disorders
• Urology Disorders
• Cognitive Disorders
• Alzheimer’s Disease
• Paralysis

By Technique

• Spinal Cord Stimulation
• Deep Brain Stimulation
• Vagus Nerve Stimulation
• Sacral Nerve Stimulation
• Transcranial Magnetic Stimulation

By Region

• North America
• Europe
• Asia-Pacific
• Rest of the world

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Neuroprosthetics Market  By Type, by application, By Technique and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
         1.1 Objectives of the Study 
         1.2 Market Definition 
         1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered                  
         1.4 Currency   
         1.5 Limitations 
         1.6 Stakeholders 
2. Research Methodology 
         2.1 Research Data 
             2.1.1 Secondary Data
                 2.1.1.1 Key Data From Secondary Sources
             2.1.2 Primary Data
                 2.1.2.1 Key Data From Primary Sources
        2.2 Market Size Estimation 
        2.3 Market Breakdown and Data Triangulation 
        2.4 Assumptions for the Study  
3. Executive Summary
        3.1 Market Outlook
        3.2 Segment Outlook
        3.3 Competitive Insights
4. Global Neuroprosthetics Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards And Compliances
5. Market Overview
     5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Neuroprosthetics Market Analysis Tools
         6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
         6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
         6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
         6.4. Market Entry Strategies
         6.5. Case Studies
7. Global Neuroprosthetics Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million)
           7.1. Output Neural Prosthetics
                 7.1.1.  Motor Prosthetics
                 7.1.2. Cognitive Prosthetics
           7.2. Input Neural Prosthetics
                 7.2.1. Cochlear Implants
                 7.2.2. Bionic Eye/Retinal Implants
8. Global Neuroprosthetics Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
           8.1. Motor Neuron Disorders
                8.1.1. Parkinson’s Disease
                8.1.2. Epilepsy
           8.2. Physiological Disorders
                8.2.1.  Auditory Processing Disorders
                8.2.2. Ophthalmic Disorders
                8.2.3. Cardiovascular Disorders
                8.2.4. Urology Disorders
           8.3. Cognitive Disorders
                8.3.1. Alzheimer’s Disease
                8.3.2. Paralysis
9. Global Neuroprosthetics Market, By Technique Historical Analysis and Forecast 2020-2027 (USD Million)
           9.1. Spinal Cord Stimulation
           9.2. Deep Brain Stimulation
           9.3. Vagus Nerve Stimulation
           9.4. Sacral Nerve Stimulation
           9.5. Transcranial Magnetic Stimulation
10.  North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) along with expected regulatory needs
     10.1. Introduction
     10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            10.2.1. U.S.A
            10.2.2. Canada
            10.2.3. Mexico
     10.3. Market Size (USD Million) Forecast for North America 2020-2027
11. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
     11.1. Introduction
     11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
           11.2.1. Germany
           11.2.2. U.K
           11.2.3. France
           11.2.4. Italy
           11.2.5. Spain
           11.2.6. Russia
           11.2.7. Poland
           11.2.8. Switzerland
           11.2.9. Rest of Western Europe
12. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) - along with expected regulatory needs
        12.1. Introduction
        12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 
             12.2.1. Japan
             12.2.2. China
             12.2.3. Singapore
             12.2.4. India
             12.2.5. Australia and New Zealand
             12.2.6. ASEAN
             12.2.7. South Korea
             12.2.8. Rest of Asia Pacific
        12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
           13.1. Introduction
           13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                     13.2.1. Saudi Arabia
                     13.2.2. UAE
                     13.2.3. South Africa
                     13.2.4. Egypt
           13.3. Market Size (USD Million) Forecast for MEA 2020-2027
  14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
         14.1. Medtronic
                14.1.1. Company Overview
                 14.1.2. Product Portfolio
                14.1.3. SWOT Analysis
                14.1.4. Financial Overview
                14.1.5. Strategic Overview
         14.2. Abbott
                14.2.1. Company Overview
                14.2.2. Product Portfolio
                14.2.3. SWOT Analysis
                14.2.4. Financial Overview
                14.2.5. Strategic Overview
         14.3. Cochlear
                14.3.1. Company Overview
                14.3.2. Product Portfolio
                14.3.3. SWOT Analysis
                14.3.4. Financial Overview
                14.3.5. Strategic Overview
         14.4. Boston Scientific
                14.4.1. Company Overview
                14.4.2. Product Portfolio
                14.4.3. SWOT Analysis
                14.4.4. Financial Overview
                14.4.5. Strategic Overview
         14.5. Livanova
                14.5.1. Company Overview
                14.5.2. Product Portfolio
                14.5.3. SWOT Analysis
                14.5.4. Financial Overview
                14.5.5. Strategic Overview
         14.6. Second Sight
                14.6.1. Company Overview
                14.6.2. Product Portfolio
                14.6.3. SWOT Analysis
                14.6.4. Financial Overview
                14.6.5. Strategic Overview
         14.7. Livanova
                14.7.1. Company Overview
                14.7.2. Product Portfolio
                14.7.3. SWOT Analysis
                14.7.4. Financial Overview
                14.7.5. Strategic Overview
         14.8. Med-El
                14.8.1. Company Overview
                14.8.2. Product Portfolio
                14.8.3. SWOT Analysis
                14.8.4. Financial Overview
                14.8.5. Strategic Overview
         14.5. Retina Implant
                14.5.1. Company Overview
                14.5.2. Product Portfolio
                14.5.3. SWOT Analysis
                14.5.4. Financial Overview
                14.5.5. Strategic Overview
         14.9. Sonova
                14.9.1. Company Overview
                14.9.2. Product Portfolio
                14.9.3. SWOT Analysis
                14.9.4. Financial Overview
                14.9.5. Strategic Overview
         14.10. Neuropace
                14.10.1. Company Overview
                14.10.2. Product Portfolio
                14.10.3. SWOT Analysis
                14.10.4. Financial Overview
                14.10.5. Strategic Overview
         14.11. NDI Medical
                14.11.1. Company Overview
                14.11.2. Product Portfolio
                14.11.3. SWOT Analysis
                14.11.4. Financial Overview
                14.11.5. Strategic Overview
         14.12. Nevro
                14.12.1. Company Overview
                14.12.2. Product Portfolio
                14.12.3. SWOT Analysis
                14.12.4. Financial Overview
                14.12.5. Strategic Overview
15. FutureWise SME key takeaway points for Client
 

Tables

Figures